MicroPort<sup>®</sup> EP Obtains CFDA Approval for EasyFinder™ 3D Steerable Curve Mapping Catheter

Shanghai, China – Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort® EP") recently obtained the regulatory approval from China Food and Drug Administration ("CFDA") for its in-house developed EasyFinder™ 3D Steerable curve mapping catheter.
 
The EasyFinder™ 3D catheter is indicated for use in cardiac electrophysioloty studies. When used with Columbus™ 3D EP Navigation System ("Columbus™") and External Reference Patch, it provides precise location of the catheter curve in the body. EasyFinder™ 3D catheter has a high-torque shaft with a deflectable curve section. The tip deflection is controlled at the proximal end by a handle. The high-torque shaft also allows the plane of the curved tip to be rotated to facilitate accurate positioning of the catheter tip at the desired site.
 
President of MicroPort® EP Yiyong Sun said: "The CFDA approval of EasyFinder™ 3D Steerable curve mapping catheter signifies a major step forward for MicroPort® EP to provide a complete electrophysiological solution for arrhythmia patients with combinations of active and passive devices and equipment."